The life sciences practice at Hogan Lovells International LLP has expertise spanning pharmaceuticals, medical devices, and healthcare regulatory issues, advising leading pharmaceutical clients on contentious and non-contentious matters. Fabien Roy acts as head of the practice, with particular knowledge of pharma, medical devices, and in vitro diagnostic devices. Cláudia Mendes Pinto is key to the team, frequently working on EU and global projects, focusing on advanced therapy medicinal products. Helene Boland and Gregoire Paquet are also noted.

HOYNG ROKH MONEGIER is the ‘go-to firm for EU regulatory matters in pharma, medical devices, and biotech’, advising across the life cycle of medical products and devices. The practice’s expertise extends to regulatory exclusives, market authorisation and access, and compliance issues, with members of the team also being skilled at handling domestic and cross-border litigation. Team head Liesbeth Weynants ‘stands out for her superb knowledge of pharma regulatory law combined with patent litigation expertise’. Tim Robrechts and Ine Letten are noted for their intellectual property expertise, with Letten also being highly knowledgeable of pharmaceutical regulatory law.

The global life sciences practice at Sidley Austin LLP acts on high-profile litigation across the medical devices and biotech sectors, with vast knowledge of regulatory agencies. Maurits Lugard leads the practice, focusing on food and beverage, drugs, and medical devices. Maarten Meulenbelt specialises in EU regulatory matters, litigation, and competition law-related matters across the life sciences sector. Also of note is Michele Tagliaferri, who is leading the firm’s compliance work.

A&O Shearman yields a dedicated life sciences team, with experience representing global pharmaceutical and biotech companies in matters spanning regulatory and intellectual property work. Peter Van Dyck leads the practice, specialising in intellectual property disputes related to the life sciences sector. Van Dyck acts as head of the team alongside Tine Carmeliet  is skilled at aiding clients dealing with EU regulations linked to the development of new medical products. Eline D’Joos is another key contact.

With expertise across the full spectrum of contentious and non-contentious healthcare and life sciences matters, the ‘very professional, diligent and creative’ team at Crowell & Moring advises a range of clients including national and international pharmaceutical companies and government entities. Team head Kristof Roox has ‘outstanding knowledge of the pharmaceutical generic industry’, combining expertise in intellectual property litigation with knowledge of pharmaceuticals and medical devices.

Described by clients as a ‘one-stop shop’, Jones Day acts on matters across the gamut of life sciences work, including pharmaceutical products, medical devices, and cosmetic products. Clients of the practice include leading pharmaceutical businesses, service providers, and medical technology manufacturers. Practice head Cristiana Spontoni is recommended for cross-border regulatory issues with focus areas such as clinical trials, pre-market authorisations, and compliance.

Simmons & Simmons has ‘strong experience and knowledge in healthcare compliance regulations’ with vast regulatory expertise linked to medical devices, biopharmaceutical products, and advanced therapy medicinal products. The team is adept at handling cross-border work, and collaborates closely with other teams of the firm. Olivier Mignolet leads the ‘professional and proactive’ practice alongside Annabelle Bruyndonckx. Dimitri Van Uytvanck is key to the team, bringing extensive employment expertise. Jérémie Doornaert is an ‘exceptional lawyer’, with experience on contentious and non-contentious matters across the pharmaceutical and medical device industries.

The life sciences practice at ALTIUS is ‘always readily available and easily accessible’, representing companies in the pharmaceutical, medical devices, and biotech industries. The team that is ‘very hands on, to the point, communicates fast, and delivers within deadlines’ is led by the experienced litigator Christophe Ronse, Philippe de Jong, and Kirian Claeyé, who is adept at life cycle management and advice on clinical trials.

The ‘specialized, experienced, responsive’ practice at Osborne Clarke advises on regulatory issues related to medical devices, medicinal products, and digital health technology and is frequently sought out by clients entering the EU market.  A ‘very good lawyer with great industry experience’, Vladimir Murovec is particularly experienced in the area of digital health technologies.

The ‘cross-functional’ practice at Reed Smith has extensive experience working with leading pharmaceutical companies, providing advice on complex regulatory issues. The team works closely with other offices of the firm, across the EU, and internationally. Team head Wim Vandenberghe‘s ‘advice is widely regarded as nothing short of brilliant’, and is ‘both technically correct, and practical’.

Ignace Vernimme and Philippe Campolini lead the life sciences practice at Stibbe, advising on complex compliance and regulatory issues. Vernimme’s experience covers IP, life science, and health products, while Campolini is well versed in advising Belgian and international clients in the medical devices and life sciences industry. The team is adept at handling related litigation, including disputes with Belgian pricing authorities. Louis Bidaine is also noted.